ProtRNA (zero-shot, Wang et al. 2026)
ProtRNA evaluated zero-shot by Wang et al. 2026.
Overview
An explanatory profile has not yet been reviewed for this record.
Consult the linked sources for architecture or protocol details. Missing evidence is not evidence of a missing capability.
Evaluations and results
36 evaluations · 36 results. Different protocols are not a single leaderboard.
Sorted by AUROC (CLS embedding; mean over random samplings of sequence pairs) (higher is better). The best value in each column is highlighted. Decimals are rounded for display; each value links to the printed value and its source.
| Tested configuration | Protocol and dataset | AUROC (CLS embedding; mean over random samplings of sequence pairs) | AUROC (FFT embedding; mean over random samplings of sequence pairs) | F1 (attention; mean over structures) | F1 (attention; median over structures) | F1 (CLS embedding; mean over random samplings of sequence pairs) | F1 (FFT embedding; mean over random samplings of sequence pairs) | MCC (attention; mean over structures) | MCC (attention; median over structures) | MCC (CLS embedding; mean over random samplings of sequence pairs) | MCC (FFT embedding; mean over random samplings of sequence pairs) | One minus overlap ratio (CLS embedding; mean over random samplings of sequence pairs) | One minus overlap ratio (FFT embedding; mean over random samplings of sequence pairs) | Absolute spearman correlation (PLL-D; mean over assays) | Absolute spearman correlation (PLL-D; median over assays) | Absolute spearman correlation (WT-LLR; mean over assays) | Absolute spearman correlation (WT-LLR; median over assays) | AUROC (PLL-D; mean over assays) | AUROC (PLL-D; median over assays) | AUROC (WT-LLR; mean over assays) | AUROC (WT-LLR; median over assays) | MCC (PLL-D; mean over assays) | MCC (PLL-D; median over assays) | MCC (WT-LLR; mean over assays) | MCC (WT-LLR; median over assays) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ProtRNA (zero-shot, Wang et al. 2026)Evaluation | Wang et al. 2026 zero-shot family classification, RfamSample (561 Rfam families), CLS embedding, AUC (mean over repeated random samplings of sequence pairs), RfamSample (561 Rfam families) (Wang et al. 2026) | 0.920±0.001 (best in column) | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported |
| ProtRNA (zero-shot, Wang et al. 2026)Evaluation | Wang et al. 2026 zero-shot RNA type classification, ArchiveII-Nr (1273 RNAs), CLS embedding, AUC (mean over repeated random samplings of sequence pairs), ArchiveII-Nr (1273 RNAs) (Wang et al. 2026) | 0.900±0.000 | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported |
| ProtRNA (zero-shot, Wang et al. 2026)Evaluation | Wang et al. 2026 zero-shot fitness, RNAGym ncRNA DMS assays (31 assays), WT-LLR, AUC (mean over assays), RNAGym ncRNA DMS assays (31 assays) (Wang et al. 2026) | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | 0.553±0.037 | Not reported | Not reported | Not reported | Not reported | Not reported |
| ProtRNA (zero-shot, Wang et al. 2026)Evaluation | Wang et al. 2026 zero-shot fitness, RNAGym ncRNA DMS assays (31 assays), WT-LLR, AUC (median over assays), RNAGym ncRNA DMS assays (31 assays) (Wang et al. 2026) | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | 0.545 | Not reported | Not reported | Not reported | Not reported |
| ProtRNA (zero-shot, Wang et al. 2026)Evaluation | Wang et al. 2026 zero-shot fitness, RNAGym ncRNA DMS assays (31 assays), WT-LLR, MCC (mean over assays), RNAGym ncRNA DMS assays (31 assays) (Wang et al. 2026) | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | 0.074±0.057 | Not reported |
| ProtRNA (zero-shot, Wang et al. 2026)Evaluation | Wang et al. 2026 zero-shot fitness, RNAGym ncRNA DMS assays (31 assays), WT-LLR, MCC (median over assays), RNAGym ncRNA DMS assays (31 assays) (Wang et al. 2026) | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | 0.067 |
| ProtRNA (zero-shot, Wang et al. 2026)Evaluation | Wang et al. 2026 zero-shot fitness, RNAGym ncRNA DMS assays (31 assays), WT-LLR, SR (mean over assays), RNAGym ncRNA DMS assays (31 assays) (Wang et al. 2026) | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | 0.107±0.076 | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported |
| ProtRNA (zero-shot, Wang et al. 2026)Evaluation | Wang et al. 2026 zero-shot fitness, RNAGym ncRNA DMS assays (31 assays), WT-LLR, SR (median over assays), RNAGym ncRNA DMS assays (31 assays) (Wang et al. 2026) | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | 0.089 | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported |
| ProtRNA (zero-shot, Wang et al. 2026)Evaluation | Wang et al. 2026 zero-shot fitness, RNAGym ncRNA DMS assays (31 assays), PLL-D, AUC (mean over assays), RNAGym ncRNA DMS assays (31 assays) (Wang et al. 2026) | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | 0.539±0.026 | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported |
| ProtRNA (zero-shot, Wang et al. 2026)Evaluation | Wang et al. 2026 zero-shot fitness, RNAGym ncRNA DMS assays (31 assays), PLL-D, AUC (median over assays), RNAGym ncRNA DMS assays (31 assays) (Wang et al. 2026) | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | 0.536 | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported |
| ProtRNA (zero-shot, Wang et al. 2026)Evaluation | Wang et al. 2026 zero-shot fitness, RNAGym ncRNA DMS assays (31 assays), PLL-D, MCC (mean over assays), RNAGym ncRNA DMS assays (31 assays) (Wang et al. 2026) | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | 0.059±0.042 | Not reported | Not reported | Not reported |
| ProtRNA (zero-shot, Wang et al. 2026)Evaluation | Wang et al. 2026 zero-shot fitness, RNAGym ncRNA DMS assays (31 assays), PLL-D, MCC (median over assays), RNAGym ncRNA DMS assays (31 assays) (Wang et al. 2026) | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | 0.055 | Not reported | Not reported |
| ProtRNA (zero-shot, Wang et al. 2026)Evaluation | Wang et al. 2026 zero-shot fitness, RNAGym ncRNA DMS assays (31 assays), PLL-D, SR (mean over assays), RNAGym ncRNA DMS assays (31 assays) (Wang et al. 2026) | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | 0.082±0.052 | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported |
| ProtRNA (zero-shot, Wang et al. 2026)Evaluation | Wang et al. 2026 zero-shot fitness, RNAGym ncRNA DMS assays (31 assays), PLL-D, SR (median over assays), RNAGym ncRNA DMS assays (31 assays) (Wang et al. 2026) | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | 0.084 | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported |
| ProtRNA (zero-shot, Wang et al. 2026)Evaluation | Wang et al. 2026 zero-shot secondary structure, TS test set (70 PDB structures), attention, F1 score (mean over structures), TS test set (70 PDB structures) (Wang et al. 2026) | Not reported | Not reported | 0.333±0.236 (best in column) | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported |
| ProtRNA (zero-shot, Wang et al. 2026)Evaluation | Wang et al. 2026 zero-shot secondary structure, TS test set (70 PDB structures), attention, F1 score (median over structures), TS test set (70 PDB structures) (Wang et al. 2026) | Not reported | Not reported | Not reported | 0.298 (best in column) | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported |
| ProtRNA (zero-shot, Wang et al. 2026)Evaluation | Wang et al. 2026 zero-shot secondary structure, TS test set (70 PDB structures), attention, MCC (mean over structures), TS test set (70 PDB structures) (Wang et al. 2026) | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | 0.351±0.237 (best in column) | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported |
| ProtRNA (zero-shot, Wang et al. 2026)Evaluation | Wang et al. 2026 zero-shot secondary structure, TS test set (70 PDB structures), attention, MCC (median over structures), TS test set (70 PDB structures) (Wang et al. 2026) | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | 0.323 (best in column) | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported |
| ProtRNA (zero-shot, Wang et al. 2026)Evaluation | Wang et al. 2026 zero-shot secondary structure, TS-Hard test set (15 PDB structures), attention, F1 score (mean over structures), TS-Hard test set (15 PDB structures) (Wang et al. 2026) | Not reported | Not reported | 0.280±0.189 | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported |
| ProtRNA (zero-shot, Wang et al. 2026)Evaluation | Wang et al. 2026 zero-shot secondary structure, TS-Hard test set (15 PDB structures), attention, F1 score (median over structures), TS-Hard test set (15 PDB structures) (Wang et al. 2026) | Not reported | Not reported | Not reported | 0.276 | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported |
| ProtRNA (zero-shot, Wang et al. 2026)Evaluation | Wang et al. 2026 zero-shot secondary structure, TS-Hard test set (15 PDB structures), attention, MCC (mean over structures), TS-Hard test set (15 PDB structures) (Wang et al. 2026) | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | 0.301±0.195 | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported |
| ProtRNA (zero-shot, Wang et al. 2026)Evaluation | Wang et al. 2026 zero-shot secondary structure, TS-Hard test set (15 PDB structures), attention, MCC (median over structures), TS-Hard test set (15 PDB structures) (Wang et al. 2026) | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | 0.295 | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported |
| ProtRNA (zero-shot, Wang et al. 2026)Evaluation | Wang et al. 2026 zero-shot family classification, RfamSample (561 Rfam families), FFT embedding, 1 − OR (mean over repeated random samplings of sequence pairs), RfamSample (561 Rfam families) (Wang et al. 2026) | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | 0.862±0.001 (best in column) | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported |
| ProtRNA (zero-shot, Wang et al. 2026)Evaluation | Wang et al. 2026 zero-shot family classification, RfamSample (561 Rfam families), FFT embedding, AUC (mean over repeated random samplings of sequence pairs), RfamSample (561 Rfam families) (Wang et al. 2026) | Not reported | 0.953±0.000 (best in column) | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported |
| ProtRNA (zero-shot, Wang et al. 2026)Evaluation | Wang et al. 2026 zero-shot family classification, RfamSample (561 Rfam families), FFT embedding, F1 (mean over repeated random samplings of sequence pairs), RfamSample (561 Rfam families) (Wang et al. 2026) | Not reported | Not reported | Not reported | Not reported | Not reported | 0.881±0.001 (best in column) | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported |
| ProtRNA (zero-shot, Wang et al. 2026)Evaluation | Wang et al. 2026 zero-shot family classification, RfamSample (561 Rfam families), FFT embedding, MCC (mean over repeated random samplings of sequence pairs), RfamSample (561 Rfam families) (Wang et al. 2026) | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | 0.761±0.001 (best in column) | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported |
| ProtRNA (zero-shot, Wang et al. 2026)Evaluation | Wang et al. 2026 zero-shot RNA type classification, ArchiveII-Nr (1273 RNAs), FFT embedding, 1 − OR (mean over repeated random samplings of sequence pairs), ArchiveII-Nr (1273 RNAs) (Wang et al. 2026) | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | 0.780±0.002 | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported |
| ProtRNA (zero-shot, Wang et al. 2026)Evaluation | Wang et al. 2026 zero-shot RNA type classification, ArchiveII-Nr (1273 RNAs), FFT embedding, AUC (mean over repeated random samplings of sequence pairs), ArchiveII-Nr (1273 RNAs) (Wang et al. 2026) | Not reported | 0.888±0.001 | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported |
| ProtRNA (zero-shot, Wang et al. 2026)Evaluation | Wang et al. 2026 zero-shot RNA type classification, ArchiveII-Nr (1273 RNAs), FFT embedding, F1 (mean over repeated random samplings of sequence pairs), ArchiveII-Nr (1273 RNAs) (Wang et al. 2026) | Not reported | Not reported | Not reported | Not reported | Not reported | 0.809±0.001 | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported |
| ProtRNA (zero-shot, Wang et al. 2026)Evaluation | Wang et al. 2026 zero-shot RNA type classification, ArchiveII-Nr (1273 RNAs), FFT embedding, MCC (mean over repeated random samplings of sequence pairs), ArchiveII-Nr (1273 RNAs) (Wang et al. 2026) | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | 0.640±0.002 | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported |
| ProtRNA (zero-shot, Wang et al. 2026)Evaluation | Wang et al. 2026 zero-shot family classification, RfamSample (561 Rfam families), CLS embedding, 1 − OR (mean over repeated random samplings of sequence pairs), RfamSample (561 Rfam families) (Wang et al. 2026) | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | 0.874±0.001 (best in column) | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported |
| ProtRNA (zero-shot, Wang et al. 2026)Evaluation | Wang et al. 2026 zero-shot family classification, RfamSample (561 Rfam families), CLS embedding, F1 (mean over repeated random samplings of sequence pairs), RfamSample (561 Rfam families) (Wang et al. 2026) | Not reported | Not reported | Not reported | Not reported | 0.866±0.000 (best in column) | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported |
| ProtRNA (zero-shot, Wang et al. 2026)Evaluation | Wang et al. 2026 zero-shot family classification, RfamSample (561 Rfam families), CLS embedding, MCC (mean over repeated random samplings of sequence pairs), RfamSample (561 Rfam families) (Wang et al. 2026) | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | 0.719±0.001 (best in column) | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported |
| ProtRNA (zero-shot, Wang et al. 2026)Evaluation | Wang et al. 2026 zero-shot RNA type classification, ArchiveII-Nr (1273 RNAs), CLS embedding, 1 − OR (mean over repeated random samplings of sequence pairs), ArchiveII-Nr (1273 RNAs) (Wang et al. 2026) | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | 0.799±0.001 | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported |
| ProtRNA (zero-shot, Wang et al. 2026)Evaluation | Wang et al. 2026 zero-shot RNA type classification, ArchiveII-Nr (1273 RNAs), CLS embedding, F1 (mean over repeated random samplings of sequence pairs), ArchiveII-Nr (1273 RNAs) (Wang et al. 2026) | Not reported | Not reported | Not reported | Not reported | 0.825±0.001 | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported |
| ProtRNA (zero-shot, Wang et al. 2026)Evaluation | Wang et al. 2026 zero-shot RNA type classification, ArchiveII-Nr (1273 RNAs), CLS embedding, MCC (mean over repeated random samplings of sequence pairs), ArchiveII-Nr (1273 RNAs) (Wang et al. 2026) | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | 0.670±0.001 | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported | Not reported |
All 36 result rows with coverage, uncertainty and sources
Filter evaluations
Applied filters: All linked evaluations
Source checking is not independent reproduction. Release 2026-10-22-1b7cf027e4f6.
Use this configuration
How it works, versions and access
Strengths, limitations and unresolved questions
Evidence
Source checking verifies the cited claim or transcription. It does not establish independent reproduction.
Evidence table
Inspect claims, sources and review details
Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.
One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.
0 evidence rows matching the loaded filters
| Property and statement | Original source and location | Review and provenance |
|---|
No evidence rows match these filters. Choose another scope or clear the search.
Sources and history
Release 2026-10-22-1b7cf027e4f6 · Record review: source checked
1 source record and release history
- Zero-shot benchmarking of RNA language models: Supplementary Information · Original source · bbag098_supplymentary_information_20260209.docx from the Europe PMC supplementary files archive for PMC12963973
Technical metadata and extraction receipts
Stable ID: lit-rna-20261011-rnalm-zeroshot-config-protrna-wang2026
- areas
- rna-transcriptomes
- contexts
- research
- method types
- foundation_model
- reported name
- ProtRNA
- foundation model eligible
- true
- parameters
- Pretrained weights used without fine-tuning (zero-shot); attention maps, embeddings or token logits read out as described in the Methods
- access reuse
- Public download location listed in Supplementary Table 1
- source locator
- Supplementary Table 1 row 'ProtRNA'
- checkpoint
- https://github.com/roxie-zhang/ProtRNA (downloaded 2024/9/24; version column '-'; variant label in results tables 'none')
- missing metadata
- version: reason: unreported; note: No version column entry for this checkpoint in Supplementary Table 1
Related records
- configuration of: ProtRNA
- system: ProtRNA zero-shot fitness on RNAGym ncRNA DMS assays (31 assays) (WT-LLR, AUC, mean)
- system: ProtRNA zero-shot fitness on RNAGym ncRNA DMS assays (31 assays) (WT-LLR, AUC, median)
- system: ProtRNA zero-shot fitness on RNAGym ncRNA DMS assays (31 assays) (WT-LLR, MCC, mean)
- system: ProtRNA zero-shot fitness on RNAGym ncRNA DMS assays (31 assays) (WT-LLR, MCC, median)
- system: ProtRNA zero-shot fitness on RNAGym ncRNA DMS assays (31 assays) (WT-LLR, SR, mean)
- system: ProtRNA zero-shot fitness on RNAGym ncRNA DMS assays (31 assays) (WT-LLR, SR, median)
- system: ProtRNA zero-shot fitness on RNAGym ncRNA DMS assays (31 assays) (PLL-D, AUC, mean)
- system: ProtRNA zero-shot fitness on RNAGym ncRNA DMS assays (31 assays) (PLL-D, AUC, median)
- system: ProtRNA zero-shot fitness on RNAGym ncRNA DMS assays (31 assays) (PLL-D, MCC, mean)
- system: ProtRNA zero-shot fitness on RNAGym ncRNA DMS assays (31 assays) (PLL-D, MCC, median)
- system: ProtRNA zero-shot fitness on RNAGym ncRNA DMS assays (31 assays) (PLL-D, SR, mean)
- system: ProtRNA zero-shot fitness on RNAGym ncRNA DMS assays (31 assays) (PLL-D, SR, median)
- system: ProtRNA zero-shot secondary structure on TS test set (70 PDB structures) (attention, F1 score, mean)
- system: ProtRNA zero-shot secondary structure on TS test set (70 PDB structures) (attention, F1 score, median)
- system: ProtRNA zero-shot secondary structure on TS test set (70 PDB structures) (attention, MCC, mean)
- system: ProtRNA zero-shot secondary structure on TS test set (70 PDB structures) (attention, MCC, median)
- system: ProtRNA zero-shot secondary structure on TS-Hard test set (15 PDB structures) (attention, F1 score, mean)
- system: ProtRNA zero-shot secondary structure on TS-Hard test set (15 PDB structures) (attention, F1 score, median)
- system: ProtRNA zero-shot secondary structure on TS-Hard test set (15 PDB structures) (attention, MCC, mean)
- system: ProtRNA zero-shot secondary structure on TS-Hard test set (15 PDB structures) (attention, MCC, median)
- system: ProtRNA zero-shot family classification on RfamSample (561 Rfam families) (FFT embedding, 1 − OR, sampled-mean)
- system: ProtRNA zero-shot family classification on RfamSample (561 Rfam families) (FFT embedding, AUC, sampled-mean)
- system: ProtRNA zero-shot family classification on RfamSample (561 Rfam families) (FFT embedding, F1, sampled-mean)
- system: ProtRNA zero-shot family classification on RfamSample (561 Rfam families) (FFT embedding, MCC, sampled-mean)
- system: ProtRNA zero-shot RNA type classification on ArchiveII-Nr (1273 RNAs) (FFT embedding, 1 − OR, sampled-mean)
- system: ProtRNA zero-shot RNA type classification on ArchiveII-Nr (1273 RNAs) (FFT embedding, AUC, sampled-mean)
- system: ProtRNA zero-shot RNA type classification on ArchiveII-Nr (1273 RNAs) (FFT embedding, F1, sampled-mean)
- system: ProtRNA zero-shot RNA type classification on ArchiveII-Nr (1273 RNAs) (FFT embedding, MCC, sampled-mean)
- system: ProtRNA zero-shot family classification on RfamSample (561 Rfam families) (CLS embedding, 1 − OR, sampled-mean)
- system: ProtRNA zero-shot family classification on RfamSample (561 Rfam families) (CLS embedding, AUC, sampled-mean)
- system: ProtRNA zero-shot family classification on RfamSample (561 Rfam families) (CLS embedding, F1, sampled-mean)
- system: ProtRNA zero-shot family classification on RfamSample (561 Rfam families) (CLS embedding, MCC, sampled-mean)
- system: ProtRNA zero-shot RNA type classification on ArchiveII-Nr (1273 RNAs) (CLS embedding, 1 − OR, sampled-mean)
- system: ProtRNA zero-shot RNA type classification on ArchiveII-Nr (1273 RNAs) (CLS embedding, AUC, sampled-mean)
- system: ProtRNA zero-shot RNA type classification on ArchiveII-Nr (1273 RNAs) (CLS embedding, F1, sampled-mean)
- system: ProtRNA zero-shot RNA type classification on ArchiveII-Nr (1273 RNAs) (CLS embedding, MCC, sampled-mean)